Terms: = Thyroid cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
153 results:
1. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract] [Full Text] [Related]
2. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
Gan DEH; Bustam AZ
J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
[TBL] [Abstract] [Full Text] [Related]
3. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
4. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract] [Full Text] [Related]
5. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: a systematic review and network meta-analysis.
Li X; Ding W; Zhang H
Front Endocrinol (Lausanne); 2023; 14():1256209. PubMed ID: 38111707
[TBL] [Abstract] [Full Text] [Related]
6. Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing.
Yu Z; Zhang Z; Liu J; Wu X; Fan X; Pang J; Bao H; Yin J; Wu X; Shao Y; Liu Z; Liu F
Mol Oncol; 2024 May; 18(5):1301-1315. PubMed ID: 37885353
[TBL] [Abstract] [Full Text] [Related]
7. Improvement in neck ultrasound report quality following the implementation of European thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
Wu J; Hu X; Seal P; Amin P; Diederichs B; Paschke R
Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37439446
[TBL] [Abstract] [Full Text] [Related]
8. Predictive biological factors for late survival in patients with HER2-positive breast cancer.
Kang YJ; Oh SJ; Bae SY; Kim EK; Lee YJ; Park EH; Jeong J; Park HK; Suh YJ; Kim YS
Sci Rep; 2023 Jul; 13(1):11008. PubMed ID: 37420033
[TBL] [Abstract] [Full Text] [Related]
9. p18INK4C and brca1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
10. Increased risk of pancreatic, thyroid, prostate and breast cancers in men with a family history of breast cancer: A population-based study.
Song H; Jung YS; Tran TXM; Moon CM; Park B
Int J Cancer; 2023 Sep; 153(5):950-957. PubMed ID: 37248785
[TBL] [Abstract] [Full Text] [Related]
11. An overview of the research progress of BRCA gene mutations in breast cancer.
Wan A; Zhang G; Ma D; Zhang Y; Qi X
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188907. PubMed ID: 37172654
[TBL] [Abstract] [Full Text] [Related]
12. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
[TBL] [Abstract] [Full Text] [Related]
13. Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
Vashistha V; Katsoulakis E; Guo A; Price M; Ahmed S; Kelley MJ
JCO Precis Oncol; 2023 Feb; 7():e2200518. PubMed ID: 36787508
[TBL] [Abstract] [Full Text] [Related]
14. Association between Poverty and Refraining from Seeking Medical Care during the COVID-19 Pandemic in Japan: A Prospective Cohort Study.
Obikane E; Nishi D; Ozaki A; Shinozaki T; Kawakami N; Tabuchi T
Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768046
[TBL] [Abstract] [Full Text] [Related]
15. BMI-1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes.
Liu JY; Jiang YN; Huang H; Xu JF; Wu YH; Wang Q; Zhu Y; Zheng B; Shen C; Qian WF; Shen J
Cancer Sci; 2023 Feb; 114(2):449-462. PubMed ID: 36285479
[TBL] [Abstract] [Full Text] [Related]
16. Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
Shirota H; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Tada H; Shimada M; Niihori T; Aoki Y; Sugiyama I; Kawamura M; Yasuda J; Suzuki S; Iwaya T; Saito M; Saito T; Shibata H; Furukawa T; Ishioka C
Cancer Med; 2023 Mar; 12(5):6170-6181. PubMed ID: 36251535
[TBL] [Abstract] [Full Text] [Related]
17. brca1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect
Liu X; Liu H; Zeng L; Lv Y
PeerJ; 2022; 10():e14052. PubMed ID: 36193432
[TBL] [Abstract] [Full Text] [Related]
18. Optimising diffusion-weighted imaging of the thyroid gland using dedicated surface coil.
Wang YF; Ren Y; Zhu CF; Qian L; Yang Q; Deng WM; Zou LY; Liu Z; Luo DH
Clin Radiol; 2022 Nov; 77(11):e791-e798. PubMed ID: 36096939
[TBL] [Abstract] [Full Text] [Related]
19. thyroid Function and COVID-19 Susceptibility and Its Severity: A Two-Sample Mendelian Randomization Study.
Zhang Z; Fang T; Chen L; Qiu B; Lv Y
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36048436
[TBL] [Abstract] [Full Text] [Related]
20. Anti-breast Adenocarcinoma and Anti-urease Anti-tyrosinase Properties of 5-Pentylresorcinol as Natural Compound with Molecular Docking Studies.
Yang X; Zhao Z; Zhao C; Li Y; El-Kott AF; Bani-Fwaz MZ
J Oleo Sci; 2022; 71(7):1031-1038. PubMed ID: 35781255
[TBL] [Abstract] [Full Text] [Related]
[Next]
